NCT02194231 2020-01-23ATREUSMario Negri Institute for Pharmacological ResearchPhase 2 Completed145 enrolled
NCT03496519 2018-10-09Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid TumorsUniversity of Colorado, DenverPhase 1 Withdrawn
NCT00027508 2015-02-24Ecteinascidin 743 in Treating Patients With Malignant MesotheliomaPharmaMarPhase 2 Terminated